Minimally invasive cortical interface that records and stimulates at the brain's surface without penetrating tissue.

Precision Neuroscience: Pioneering minimally invasive brain-computer interfaces for neurological treatments.
Precision Neuroscience, founded in 2021 and based in New York, is dedicated to developing next-generation brain-computer interface (BCI) technology. The company's core mission is to deliver life-changing BCI solutions to millions of people suffering from neurological illnesses. Their flagship product, the Layer 7 Cortical Interface, is a minimally invasive implant designed to conform to the brain's surface without damaging tissue. This innovative device is capable of processing large amounts of data and can be safely removed, offering a breakthrough in neurological treatments.
Precision Neuroscience has garnered attention for its pioneering approach and has attracted notable investors and advisors from both the medical and tech industries. The company has achieved significant milestones, including successful preclinical trials and securing substantial funding to advance its research and development. By focusing on creating safe, effective, and scalable BCI solutions, Precision Neuroscience is poised to make a profound impact on the treatment of neurological disorders, potentially improving the quality of life for millions worldwide.
Companies similar to Precision Neuroscience include Bios Health, Neuralink, Precision Neuroscopics and ni2o.
Precision Neuroscience was founded in 2021.
Precision Neuroscience's headquarters is located in New York City, NY, US.
Precision Neuroscience's most recent funding round was for $41M (USD) in January 2023.
As of Jan 25, 2023, Precision Neuroscience has raised a total of $53M (USD).
Precision Neuroscience has 34 employees as of Feb 5, 2024.
Precision Neuroscopics